Publication | Closed Access

Results of docetaxel plus oxaliplatin (DOCOX)±cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised Phase 2 study

Esophageal CancerGastrointestinal OncologyMedicineRandomised Phase 2GastroenterologyPathologyCancer TreatmentOncologyRadiation OncologyCancer Research